Topoisomerase I expression is associated with prognosis in postoperative non-small cell lung cancer patients

Lu Baohua; Zhang Hongmei; Zhang Tongmei; Cai Yiran; Hu Ying; Zheng Hua; Li Baolan

首页> 外文期刊>Thoracic cancer. >Topoisomerase I expression is associated with prognosis in postoperative non-small cell lung cancer patients

【24h】

Topoisomerase I expression is associated with prognosis in postoperative non-small cell lung cancer patients

机译：拓扑异构酶I表达与术后非小细胞肺癌患者的预后相关

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: Biomarkers may help to improve non-small cell lung cancer (NSCLC) prognosis. However, the prognostic effect of topoisomerase I (Topo I) on NSCLC is unknown. We evaluated the clinicopathologic and prognostic significance of tumor Topo I and thymidylate synthase (TS) protein expression in postoperative NSCLC patients.

机译：背景：生物标志物可能有助于改善非小细胞肺癌（NSCLC）的预后。但是，拓扑异构酶I（Topo I）对NSCLC的预后作用尚不清楚。我们评估了术后Topo I和胸苷酸合酶（TS）蛋白表达在NSCLC术后患者中的临床病理和预后意义。

著录项

来源
《Thoracic cancer.》 |2016年第4期|共9页
作者
Lu Baohua; Zhang Hongmei; Zhang Tongmei; Cai Yiran; Hu Ying; Zheng Hua; Li Baolan;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词
Non-small cell lung cancer; prognosis; topoisomerase I;

机译：非小细胞肺癌;预后;拓扑异构酶I;

相似文献

外文文献
中文文献
专利

1. Topoisomerase I expression is associated with prognosis in postoperative non-small cell lung cancer patients [J] . Lu Baohua, Zhang Hongmei, Zhang Tongmei, Thoracic cancer. . 2016,第4期

机译：拓扑异构酶I表达与术后非小细胞肺癌患者的预后相关
2. Topoisomerase II alpha expression and the benefit of adjuvant chemotherapy for postoperative patients with non-small cell lung cancer [J] . Shi Yan, Jiao Shun-Chang, Chen Li, BMC Cancer . 2010,第1期

机译：非小细胞肺癌术后患者拓扑异构酶IIα表达及辅助化疗的益处
3. Topoisomerase I expression is associated with prognosis in postoperative non‐small cell lung cancer patients [J] . Lu Baohua, Zhang Hongmei, Zhang Tongmei, Thoracic cancer. . 2016,第4期

机译：拓扑异构酶I表达与术后非小细胞肺癌患者的预后相关
4. Development of a radiogenomic biomarker for tumor characterization and prognosis in Non-Small Cell Lung Cancer patients [C] . Apurva Singh, Zhuoyang Wang, Sharyn Katz, Conference on Medical Imaging: Computer-Aided Diagnosis . 2021

机译：非小细胞肺癌患者肿瘤表征和预后的辐射瘤生物标志物的发展
5. The cost effectiveness of screening for early stage lung cancer and the testing and treatment of molecular subgroups among non-small cell lung cancer patients in the province of ontario, canada [D] . Thao, Mallory. 2014

机译：加拿大安大略省非小细胞肺癌患者早期肺癌筛查的成本效益及分子亚群的检测和治疗
6. Topoisomerase II alpha expression and the benefit of adjuvant chemotherapy for postoperative patients with non-small cell lung cancer [O] . Shi Yan, Jiao Shun-Chang, Chen Li, 2010

机译：非小细胞肺癌术后患者拓扑异构酶IIα的表达及辅助化疗的益处
7. Topoisomerase II alpha expression and the benefit of adjuvant chemotherapy for postoperative patients with non-small cell lung cancer [O] . Shi Yan, Jiao Shun-Chang, Chen Li, 2010

机译：非小细胞肺癌术后患者拓扑异构酶IIα的表达及辅助化疗的益处

Topoisomerase I expression is associated with prognosis in postoperative non-small cell lung cancer patients

摘要

著录项

相似文献

相关主题

期刊订阅